Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (771-780 of 934) with videos related to

Pageof 94
Sort By:
American Heart Journal|November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registryB M Scirica, D J Moliterno, N R Every, et al.
Clinical Cardiology|July 4, 2012
Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelinesPei-Hsiu Huang, Charles X Kim, Amir Lerman, et al.
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
Journal of the American College of Cardiology|December 24, 2019
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary SyndromesAmy A Sarma, Eugene Braunwald, Christopher P Cannon, et al.
Journal of Clinical Lipidology|March 21, 2020
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|May 25, 2005
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain CentersW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
Annals of Emergency Medicine|July 28, 2005
Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency departmentW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
JAMA Network Open|April 24, 2023
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an AnticoagulantChristopher P Cannon, Joseph M Kim, Jane J Lee, et al.
Pageof 94

Showing results (771-780 of 934) with videos related to

Sort By:
Pageof 94
American Heart Journal|November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registryB M Scirica, D J Moliterno, N R Every, et al.
Clinical Cardiology|July 4, 2012
Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelinesPei-Hsiu Huang, Charles X Kim, Amir Lerman, et al.
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
Journal of the American College of Cardiology|December 24, 2019
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary SyndromesAmy A Sarma, Eugene Braunwald, Christopher P Cannon, et al.
Journal of Clinical Lipidology|March 21, 2020
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|May 25, 2005
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain CentersW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
Annals of Emergency Medicine|July 28, 2005
Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency departmentW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
JAMA Network Open|April 24, 2023
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an AnticoagulantChristopher P Cannon, Joseph M Kim, Jane J Lee, et al.
Pageof 94